Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis

Clinical trial NCT03667690 · COMPLETED

Trial details

NCT number: NCT03667690
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Candidemia Mycoses Fungal Infection Invasive Candidiases

Start date: 2018-10-07
Primary completion: 2021-10-07
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.